TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
SCYX

Scynexis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.90$ +6.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement SCYX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– -79.5% +0.0% +0.0% +0.0% -52.9% +9,858.7% +9.2% -61.3% +2,652.7% -97.3% +449.9%
– +84.8% -1.8% -5.4% -100.0% – – +3.0% +101.3% +2,387.9% -100.0% –
– – +0.0% +0.0% +0.0% -52.9% -350.4% – -65.3% +2,690.0% -97.0% +449.9%
– +98.4% +22.1% -8.7% +17.6% +78.1% -4.9% -34.9% +14.7% +13.5% -14.6% -15.6%
– +60.8% -34.3% +3.2% +5.2% +22.7% +37.4% +241.3% +26.1% -47.1% -56.6% -0.4%
– +79.9% -1.9% -5.3% +13.8% +62.2% +3.7% +44.9% +22.4% -42.5% -21.2% -10.2%
– – – – – – – – – – -151.1% –
– -98.6% +4,000.0% +311.3% +10.7% +5.0% -45.2% +235.6% +71.3% -9.8% -58.3% -93.2%
– – – – – – – – – – -131.5% –
– – – +428.5% -463.1% – -306.6% – – – +9.4% –
– – – – – – – – – – -131.8% –
– – – – – – – – – – -126.2% –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?